Taniguchi, Yuri
Okamoto, Hiroaki
Shimokawa, Tsuneo
Sasaki, Tomonari
Seto, Takashi
Niho, Seiji
Ohe, Yuichiro
Saigusa, Yusuke
Article History
Received: 10 October 2021
Accepted: 22 December 2021
First Online: 9 January 2022
Declarations
:
: This study was approved by the Yokohama Municipal Citizen’s hospital ethics committee and was certified as having been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: The ‘Ethical guidelines for medical and health research involving human subjects’ published in February 2017 by the Ministry of Health, Labor and Welfare were applied. Since existing information was all anonymous, informed consent was not necessary. However, to ensure appropriate respect was paid to participants, an opt-out option was available via Yokohama City Citizen’s Hospital and the WJOG home page. The information provided on the website included the purpose of this study, how the data would be utilized, what data would be used, who would analyze the data, what institution was responsible for managing the information, and our contact number/e-mail address. More importantly, the option of refusing participation was clearly indicated.
: Dr. Taniguchi, Dr. Sasaki, and Dr. Saigusa have nothing to disclose. Dr. Okamoto reports grants from Bristol Myers Squibb, Chugai, Taiho, Astellas, Eli Lilly, Merck BioPharma. He received a lecture fee from AstraZeneca, MSD, Chugai, Boehringer Ingelheim, Bristol Myers Squibb, Novartis, and Kyorin. Dr. Shimokawa reports grants from Bristol-Myers Squibb, Chugai Pharma, Taiho Pharmaceutical, and AstraZeneca. Dr. Seto reports personal fees from AstraZeneca, Bristol-Myers Squibb, Chugai Pharmaceutical, Covidien Japan, Daiichi Sankyo, Eli Lilly Japan, Kyowa Hakko Kirin, MSD, Mochida Pharmaceutical, Nippon Boehringer Ingelheim, Novartis Pharma, Ono Pharmaceutical, Pfizer Japan, Taiho Pharmaceutical, Takeda Pharmaceutical, and Thermo Fisher Scientific. He reports grants from Abbvie, Chugai Pharmaceutical, Daiichi Sankyo, Eli Lilly Japan, Kissei Pharmaceutical, Merck Biopharma, MSD, and Novartis Pharma outside the submitted work. He is employed by Precision Medicine Asia. Dr. Niho reports grants and personal fees from Taiho Pharmaceutical and Eli Lilly Japan during the conduct of the study. He received grants and personal fees from AstraZeneca, Pfizer, Boehringer Ingelheim, MSD, Chugai Pharma, Ono Pharmaceutical, and Takeda. He received personal fees from Kyorin, Janssen, Novartis; grants from Merck Serono; and grants from Sanofi, Shionogi, and Teijin Pharma outside the submitted work. Dr. Ohe reports grants and personal fees from AstraZeneca, Amgen, Bristol Myers Squibb Japan, Eli Lilly, Janssen, Kyorin, Nippon Kayaku, Novartis, Ono Pharmaceutical, MSD, Pfizer, Taiho, Takeda Pharmaceutical, and Chugai. He received personal fees from Boehringer Ingelheim, Celtrion, and grants from Kissei.